New Jersey Medical School Clinical Research Center is the only site in the state participating in a worldwide effort to enroll 3,800 HIV negative individuals in the first Phase 3 HIV vaccine efficacy trial conducted in more than a decade. To read the full article.
Recent Posts
- One Rule Change Would Help Tens of Thousands of New Jersey Families Pay for Childcare
- Advanced Models Offer Scientists a Promising Tool to Better Understand Brain Disorders
- NJIT Computing Professor Zhi Wei Named Fellow of AAAS, Follows IEEE Honor.
- Alzheimer’s Early Detection Tests Using Video Games Could Be As Effective as Blood Tests and Boost Clinical Trials.
- Princeton joins new cancer research hub established with gift from Weill Family Foundation.
Categories
- Community (2,240)
- Covid (985)
- CTO Events (6)
- News (2,854)
- Pilots (21)